Radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer

The large-scale study of quantitative features extracted from routine medical images has been shown to provide valuable prognostic information across cancer types. We are developing new techniques to improve the integration of those features with the underlying cellular and molecular data to provide a full, multi-scale, “radiogenomic” description of the disease.

Join Dr Mireia Crispin, Professor Evis Sala (St John’s 1996) and Dr Ramona Woitek as they discuss the new developments in radiogenomics. Following the discussion, there will be an opportunity to ask your questions.